Minoo, Japan

Hiromichi Fujioka

This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiromichi Fujioka. Retrieved from https://idiyas.com/inventor/hiromichi-fujioka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 19.0

ph-index = 1

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiromichi Fujioka: Innovator in Indole Derivatives

Introduction

Hiromichi Fujioka is a notable inventor based in Minoo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his work on indole derivatives. His innovative research has the potential to impact various clinical fields.

Latest Patents

Fujioka holds a patent for novel indole derivatives and salts, represented by a specific general formula. These compounds exhibit an inhibitory effect against superoxide released from macrophage cells and demonstrate anti-albuminuria activity against Masugi nephritis. His work is particularly relevant for treating autoimmune diseases, arteriosclerosis, ischemic diseases, hepatic insufficiency, and renal insufficiency.

Career Highlights

Fujioka is associated with Otsuka Pharmaceutical Company, Limited, where he continues to advance his research. His dedication to innovation in pharmaceuticals has positioned him as a key figure in the industry.

Collaborations

He has collaborated with notable coworkers, including Hitoshi Tone and Seiji Sato, contributing to a dynamic research environment.

Conclusion

Hiromichi Fujioka's work on indole derivatives showcases his commitment to addressing critical health issues through innovative solutions. His contributions are expected to have a lasting impact on the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…